The ongoing insurance cost-cutting has impacted hemophilia deeply, particularly since we are flashing beacon on payers’ radar. One of the most prominent impacts has been forced home care switching. Reactions by families include irritation at being switched without forewarning; anger at being switched without any say in the matter; and fear at being switched to a company that has no experience with hemophilia.
Read the current issue of PEN, which delves deeply into what is happening, why, and how this could impact you. We interview 17 patients and opinion leaders to see how forced switching is impacting lives. What we do know is this: forced switching is not something that can easily be reversed, and it is definitely a cost-cutting tactic that is here to stay. Tims are changing–read PEN to learn about all the changes and how to adapt while best protecting your loved ones with bleeding disorders. If you are not on our mailing list, please contact us to sign up! It’s free to patients, HTCs and nonprofits.
2 thoughts on “Would You Rather Fight Than Switch?”
The May Issue of the PEN newsletter is outstanding. Thank you again for showing us what is going on. The page with the 3 PBM ships and their passenger lists is a very good way of looking at the big picture of providers. The providers that are on the passenger lists are not always telling consumers this up front. Also, Thanks to those who share their stories about being forced to switch. The more we talk about these problems the more likely we are to get what we deserve.
We should not have to stand by helpless while insurance companies become total dictators. I really like reading the HemaBlog. Thanks Laurie for posting from around the world.
Tom Albright
Also good to see there is a new Camp for Girls. There is a great need for this. Good luck with the book on inhibitors. I will pass on the word that you are looking for stories. The book will help many people better understand inhibitors which will help people be treated properly. The book should help those with inhibitors feel less alone.
Tom